Enfusion(ENFN) - 2024 Q1 - Quarterly Report

Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40949 Enfusion, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdic ...